Prolific Sleep Researcher Christian Guilleminault Dies

He was involved in the first identification and classification of sleep disorders and outlined protocols for the diagnosis and treatment of sleep apnea.

Written bySanjeet Bagcchi
| 2 min read
Christian Guilleminault stanford sleep center

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Christian Guilleminault, a pioneer of modern sleep medicine, died on July 9 at the age of 80 from complications due to metastatic prostate cancer.

Popular as “CG” among his colleagues at the Stanford University School of Medicine, Guilleminault was involved in the first identification and classification of sleep disorders, according to the World Sleep Society. For instance, in 1993, he coined and described “upper airway resistance syndrome”—a type of disordered breathing during sleep that doesn’t cause reduced oxygenation as seen in obstructive sleep apnea but leads to sleep microfragmentation.

“The description of the ‘upper airway resistance syndrome’ may be his greatest contribution to sleep medicine—it changed the way breathing abnormalities in sleep were conceptualized,” says Robert Thomas, an assistant professor at Harvard Medical School and the Sleep Medicine Fellowship director at Beth Israel Deaconess Medical Center. Before, doctors only noted breathing problems in sleep if they included hypoxic events.

Guilleminault ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies